RETRACTED: EMP3, which is regulated by miR-663a, suppresses gallbladder cancer progression via interference with the MAPK/ERK pathway

Cancer Lett. 2018 Aug 28:430:97-108. doi: 10.1016/j.canlet.2018.05.022. Epub 2018 May 17.

Abstract

This article has been retracted: please see Elsevier Policy on Article Withdrawal (http://www.elsevier.com/locate/withdrawalpolicy). This article has been retracted at the request of the Editor. Following the publication of the above article, the Editor was notified that images were duplicated in the migration and invasion experiments in Figures 3A, 6C, 7D and 8D: https://pubpeer.com/publications/76E82FD26E33503D7CCAC01C324AFA. The Editor has taken the decision to retract the paper as it is no longer acceptable in its current form

Keywords: EMP3; Gallbladder cancer; MAPK/ERK; miR-663a.

Publication types

  • Research Support, Non-U.S. Gov't
  • Retracted Publication

MeSH terms

  • Animals
  • Cell Line, Tumor
  • Cell Proliferation / genetics
  • Cholecystectomy
  • Disease Progression
  • Down-Regulation / genetics
  • Female
  • Gallbladder / pathology
  • Gallbladder / surgery
  • Gallbladder Neoplasms / genetics
  • Gallbladder Neoplasms / mortality
  • Gallbladder Neoplasms / pathology*
  • Gallbladder Neoplasms / surgery
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Kaplan-Meier Estimate
  • MAP Kinase Signaling System / genetics*
  • Male
  • Membrane Glycoproteins / genetics*
  • Membrane Glycoproteins / metabolism
  • Mice
  • Mice, Nude
  • MicroRNAs / metabolism*
  • Middle Aged
  • Neoplasm Staging
  • Xenograft Model Antitumor Assays

Substances

  • EMP3 protein, human
  • MIRN663 microRNA, human
  • Membrane Glycoproteins
  • MicroRNAs